Benjamin Francis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benjamin Francis has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Eduard Puente-Massaguer
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA
2 shared publications - Irene González-Domínguez
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2 shared publications - Madhumathi Loganathan
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA
2 shared publications - Weina Sun
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2 shared publications - Annika Beyer
Institute of Virology, Campus Charité Mitte, Charité - , 10117 Berlin
1 shared publication Florian Krammer
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, United States; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States
1 shared publication
Latest Publications
- Open Access
- 15 September 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (37) , eadi4753
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
Seasonal influenza virus vaccines are effective when they are well matched to circulating strains. Because of antigenic drift/change in the immunodominant hemagglutinin (HA) head domain, annual vaccine reformulations are necessary to maintain a match with circulating strains. In addition, seasonal vaccines provide little to no protection against newly emerging pandemic strains. Sequential vaccination with chimeric HA (cHA) constructs has been proven to direct the immune response toward the immunosubdominant but more conserved HA stalk domain. In this study, we show that immunization with group 2 cHA split vaccines in combination with the CpG 1018 adjuvant elicits broadly cross-reactive antibodies against all group 2 HAs, as well as systemic and local antigen-specific T cell responses. Antibodies elicited after sequential vaccination are directed to conserved regions of the HA such as the stalk and the trimer interface and also to the N2 neuraminidase (NA). Immunized mice were fully protected from challenge with a broad panel of influenza A viruses.
- 15 September 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (37) , eadi4753
Open AccessChimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
Seasonal influenza virus vaccines are effective when they are well matched to circulating strains. Because of antigenic drift/change in the immunodominant hemagglutinin (HA) head domain, annual vaccine reformulations are necessary to maintain a match with circulating strains. In addition, seasonal vaccines provide little to no protection against newly emerging pandemic strains. Sequential vaccination with chimeric HA (cHA) constructs has been proven to direct the immune response toward the immunosubdominant but more conserved HA stalk domain. In this study, we show that immunization with group 2 cHA split vaccines in combination with the CpG 1018 adjuvant elicits broadly cross-reactive antibodies against all group 2 HAs, as well as systemic and local antigen-specific T cell responses. Antibodies elicited after sequential vaccination are directed to conserved regions of the HA such as the stalk and the trimer interface and also to the N2 neuraminidase (NA). Immunized mice were fully protected from challenge with a broad panel of influenza A viruses.